Clinical Trials Sponsored by Cellaion SA

Total 1193 results

Cellaion SA

Terminated

Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF) (DHELIVER)

Acute on Chronic Liver Failure

Belgium, Spain, France, Austria, Denmark, Latvia, Germany, Bulgaria, Poland, Estonia, Italy, Lithuania, North Macedonia, Slovakia
Cellaion SA

Enrolling by invitation

HepaStem Long-Term Safety Registry (PROLONGSTEM)

Urea Cycle Disorder | Crigler-Najjar Syndrome | Acute on Chronic Liver Failure

Belgium, Spain, France, Bulgaria, Poland
Helsinn Healthcare SA
Celerion

Completed

Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects (HVFE)

Healthy Volunteers | Non-smokers | Moderate to Heavy Smokers

United States
Cyril Pellaton
Aktiia SA

Completed

Single-center Prospective Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Ambulatory Blood Pressure Monitoring (ABPM) (OBPM_ABPM2020)

Hypertension | Blood Pressure

Switzerland
Medical Device Works NV SA
Celerion; Cromsource

Unknown

Liver-PILP First-in-Man (PILP FiM)

Liver Metastases

Belgium
Celladon Corporation

Completed

A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure (CUPID-2b)

Heart Failure | Cardiomyopathies | Ischemic Cardiomyopathy | Non-ischemic Cardiomyopathy

United States, United Kingdom, Belgium, Germany, Poland, Israel, Netherlands, Hungary, Denmark, Sweden
Celladon Corporation

Terminated

A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

Heart Failure | Cardiomyopathies | Ischemic Cardiomyopathy | Non-ischemic Cardiomyopathy

United States
Celladon Corporation

Completed

Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure (CUPID)

Dilated Cardiomyopathy | Heart Failure, Congestive

United States
Celltrion

Recruiting

Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects

Healthy Subjects

Korea, Republic of
Celltrion

Recruiting

A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects

Healthy Subjects

Korea, Republic of
Celltrion

Terminated

An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

Rheumatoid Arthritis

Korea, Republic of
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)

Crohn's Disease

France, Turkey, Czechia, Greece, Latvia, Hungary, Belarus, Israel, United States, Spain, Bulgaria, Serbia, Croatia, Italy, Germany, India, Japan, Mexico, Moldova, Republic of, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa and more
Celltrion

Completed

To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria (omalizumab)

Chronic Spontaneous Urticaria

Poland
Celltrion

Completed

To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects

Healthy

Australia
Celltrion

Completed

A Food Effect Study of CT-L01 After Oral Administration in Healthy Volunteers

Healthy

Korea, Republic of
Celltrion

Completed

A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers

Healthy

Korea, Republic of
Celltrion

Active, not recruiting

To Compare Efficacy and Safety of CT-P16 and EU-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Adenocarcinoma of Lung

Korea, Republic of
Celltrion

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects

SARS-CoV-2 Infection

Poland
Celltrion

Withdrawn

To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen

COVID-19
Celltrion

Completed

A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection

SARS-CoV-2 Infection

Korea, Republic of
Celltrion

Completed

To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects

Healthy

Korea, Republic of
Celltrion

Completed

A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Bulgaria
Celltrion

Completed

To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma

Follicular Lymphoma

Korea, Republic of
Celltrion

Completed

A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model

Influenza A

United Kingdom
Celltrion

Unknown

Evaluate Safety, Efficacy and Pharmacokinetics (Compare)

Metastatic Breast Cancer

Korea, Republic of
Celltrion

Completed

Long-Term Efficacy and Safety of CT-P10 in Patients With RA

Rheumatoid Arthritis

Korea, Republic of
Celltrion

Completed

Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis (Triad RA)

Rheumatoid Arthritis

Korea, Republic of
Celltrion

Recruiting

A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps

Rheumatoid Arthritis | Psoriasis | Psoriatic Arthritis | Ankylosing Spondylitis

France
Celltrion

Not yet recruiting

A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis
Celltrion

Not yet recruiting

A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)

Ulcerative Colitis

Poland
Celltrion

Completed

Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects

Healthy Subject

Korea, Republic of
Celltrion

Completed

A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers

Essential Hypertension

Korea, Republic of
Celltrion

Completed

A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis

Psoriasis

Estonia
Celltrion

Completed

A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers

Healthy

Korea, Republic of
Celltrion

Completed

A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers

Healthy

Korea, Republic of
Celltrion

Terminated

A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection

Influenza A

Korea, Republic of
Celltrion

Completed

PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis (rituximab)

Rheumatoid Arthritis
Celltrion

Completed

To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

China
Celltrion

Completed

A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects

Healthy Male Subjects

Australia
Celltrion

Completed

Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects

Healthy Subjects

New Zealand
Celltrion

Completed

To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17

Healthy

United States
Celltrion

Completed

A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis

Crohn's Disease | Ulcerative Colitis (Part 2 Only)

Korea, Republic of
Celltrion

Completed

To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin

Healthy

Korea, Republic of
Celltrion

Completed

To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan (rituximab)

Lymphoma, Follicular
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects

Health, Subjective

United States
Celltrion

Completed

An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1

Rheumatoid Arthritis

Korea, Republic of
Celltrion

Completed

Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin

Healthy Volunteers

United States
Celltrion

Unknown

Demonstrate Efficacy and Safety of Metastatic Breast Cancer (Compare)

Metastatic Breast Cancer

Romania
Celltrion

Recruiting

A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis

Relapsing-remitting Multiple Sclerosis

Poland

3

Subscribe